Volume 111, Issue 1, January 2013

ISSN: 0167-594X (Print) 1573-7373 (Online)

In this issue (13 articles)

  1. No Access

    Topic Review

    EGFR mutation status in brain metastases of non-small cell lung carcinoma

    Fanny Burel-Vandenbos, Damien Ambrosetti, Michael Coutts… Pages 1-10
    Look Inside Get Access

  2. No Access

    Laboratory Investigation

    The role of LAT1 in 18F-DOPA uptake in malignant gliomas

    Ryan S. Youland, Gaspar J. Kitange, Timothy E. Peterson… Pages 11-18
    Look Inside Get Access

  3. No Access

    Clinical Study

    Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma

    Kevin Petrecca, Marie-Christine Guiot, Valerie Panet-Raymond… Pages 19-23
    Look Inside Get Access

  4. No Access

    Clinical Study

    Post-treatment T1 shortening in primary CNS lymphoma

    Sasan Karimi, Vaios Hatzoglou, Vineet Punia, Sasan Partovi… Pages 25-31
    Look Inside Get Access

  5. No Access

    Clinical Study

    A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806)

    Brian M. Alexander, Meihua Wang, W. K. Alfred Yung… Pages 33-39
    Look Inside Get Access

  6. No Access

    Clinical Study

    Continuous daily sunitinib for recurrent glioblastoma

    Teri Nguyen Kreisl, Perry Smith, Joohee Sul, Carlos Salgado… Pages 41-48
    Look Inside Get Access

  7. No Access

    Clinical Study

    Factors affecting peritumoral brain edema in meningioma: special histological subtypes with prominently extensive edema

    Tadashi Osawa, Masahiko Tosaka, Masaya Nagaishi… Pages 49-57
    Look Inside Get Access

  8. No Access

    Clinical Study

    Anaplastic PXA in adults: case series with clinicopathologic and molecular features

    Yao Schmidt, B. K. Kleinschmidt-DeMasters, Dara L. Aisner… Pages 59-69
    Look Inside Get Access

  9. No Access

    Clinical Study

    MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas

    Simon Kjær Hermansen, Rikke Hedegaard Dahlrot… Pages 71-81
    Look Inside Get Access

  10. No Access

    Clinical Study

    Epilepsy in the end-of-life phase in patients with high-grade gliomas

    Andrea Pace, Veronica Villani, Cherubino Di Lorenzo… Pages 83-86
    Look Inside Get Access

  11. No Access

    Letter to the Editor

    Outcome of discontinuing bevacizumab prior to malignant glioma progression

    Wendy J. Sherman, Jeffrey J. Raizer, Sean A. Grimm Pages 87-89
    Look Inside Get Access

  12. No Access

    Acknowledgement

    Acknowledgement of reviewers 2011

    Pages 91-94
    Look Inside Get Access

  13. Erratum

    Erratum to: The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas

    T. A. Juratli, M. Kirsch, K. Geiger, B. Klink, E. Leipnitz… Page 95
    Download PDF (107KB) View Article